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Background: Children with cystic ﬁbrosis (CF) tend to suffer from chronic systemic inﬂammation and may have impaired growth associated with
muscle catabolism. Therefore, investigating which type of exercise can elicit an anabolic response with minimal inﬂammation is of clinical value.
Methods: Twelve children with CF (mean±SD; age: 14.7±2.3 years, predicted FEV1: 90.0±21.6%) and biological age-matched controls (age:
13.9±2.1 years) completed moderate-intensity, continuous exercise (MICE) and high-intensity, intermittent exercise (HIIE) on separate days. Dur-
ing each exercise, blood was drawn at various time points and analyzed for immune cells, inﬂammatory cytokines, and growth mediators.
Results: At rest, children with CF had higher concentrations of neutrophils and IL-6 compared with controls. In children with CF, HIIE did not
affect immune cell subsets or cytokines: TNF-α, IL-6, and tumor necrosis factor-like weak inducer of apoptosis (TWEAK). All immune cell sub-
sets and IL-6 increased signiﬁcantly with MICE in both groups. Growth hormone (GH) increased with both types of exercise, with a greater change
from rest during MICE.
Conclusions: HIIE was a sufﬁcient stimulus to increase GH in children with CF, without affecting systemic inﬂammation.
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Children with cystic fibrosis (CF) are known to experience
chronic systemic inflammation [1], which has been associated
with increased protein breakdown and lower fat-free mass [2].
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doi:10.1016/j.jcf.2011.10.001leading to malnutrition [4] can also result in reduced fat free
mass. Exercise is a non-pharmacological approach to attenuat-
ing protein breakdown [5] and increasing fat-free mass in
humans [6]. In healthy children, however, acute bouts of exer-
cise are known to activate the same inflammatory mediators in-
volved in the pathology of CF [1]. The effect of exercise on
inflammation raises the possibility that some forms of exercise
should be avoided by children with CF. Alternatively, anabolic
processes are also triggered by exercise, which stimulates the
release of growth factors [1]. The anabolic effects of exercise
are likely to be beneficial to children with CF since poor mus-
cular development and retention is a common characteristic of
the disease [7].
While many research studies have shown that exercise im-
parts numerous benefits to children with CF [8–11], the inflam-
matory and growth factor response to exercise has not beenby Elsevier B.V. All rights reserved.
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greater increase in inflammatory cytokines (e.g., interleukin 6
[IL-6] and tumor necrosis factor alpha [TNF-α]), but a similar
growth hormone (GH) response in children with CF compared
to healthy children [1].
GH is a growth mediator, and binding to its receptor leads to
the production of insulin-like growth factor 1 (IGF-1) in muscle
[12]. IGF-1 is responsible for activating growth pathways [13],
as well as preventing muscle degradation [14]. GH has been tra-
ditionally given for catch up height; however, the evidence now
points to broader functional effects of GH, such as improved
strength, and muscle mass [15]. In the specific context of children
with CF, exogenously-administered GH also has a direct effect
on whole body protein balance [16]. In this way, GH has an
anabolic effect on the muscle, potentially through reduced
inflammation [16]. It is therefore intriguing to think that regular
exercise-induced production of GH could have similar endoge-
nous benefits.
The relationship between IL-6 and muscle catabolism is
equivocal. Some studies have reported that IL-6 is associated
with reduced growth rates and skeletal muscle development
[17–19], while others have found no change in the rate of mus-
cle protein breakdown [20,21]. Despite conflicting findings, IL-
6 is capable of promoting protein degradation [22] and baseline
concentrations are higher at rest in children with CF than
healthy children [1], making it a cytokine of interest.
The inflammatory cytokine, TNF-α, promotes skeletal mus-
cle protein degradation and inhibits skeletal muscle growth and
regeneration. This is achieved by its ability to reduce circulat-
ing GH and IGF-1 concentrations [23], promote GH resistance
in skeletal muscle [12,24], inhibit muscle production of IGF-1
[12,25], and contribute to lower IGF-1 protein content in mus-
cles [23]. In addition, increased levels of TNF-α increase rates
of muscle protein degradation [26]. Given the catabolic effects
of TNF-α, elevating levels should be avoided to promote mus-
cle growth.
Tumor necrosis factor related weak inducer of apoptosis
(TWEAK) is a novel cytokine recently identified in humans
[27]. It has been classified as a member of the TNF cytokine fam-
ily for having similar TNF properties, such as providing long-
range signaling [27]; however, unlike TNF-α, TWEAK has been
found to have longer lasting effects [28]. TWEAK is involved in
skeletal muscle degradation. Mice treated with TWEAK and
mice genetically modified to over express TWEAK have lower
body and skeletal muscle mass [29]. Furthermore, TWEAK is in-
volved in the inflammatory response in human bronchial epithelial
cell lines [30]. Due to its catabolic effects on muscle and inflam-
matory effects in the lungs, the exercise response to TWEAK
may be clinically relevant to the CF population.
Given that many exercise recommendations for children
with CF commonly take the form of endurance training to im-
prove aerobic fitness [8,10], it is reasonable to better under-
stand how this form of exercise affects inflammatory and
growth mediators. In adult studies, several inflammatory medi-
ators are thought to be more duration-dependent than intensity-
dependent, such as neutrophils [31] and IL-6 [32]. Brief but in-
tense bouts of exercise reflect the natural physical activitypatterns of young children [33–35], with some evidence that
children with CF receive greater enjoyment from this type of
exercise [9]. We were therefore interested in examining the in-
flammatory and growth factor response to this type of exercise
(brief but intense), which more closely reflects the natural be-
haviors and activity patterns of young children and may, there-
fore, be more conducive to anabolic processes [36]. Indeed, the
health benefits of high intensity interval training among adults
have received considerable attention in recent years [37–39];
high intensity interval training is essentially replicating the nat-
ural physical activity patterns of children. Thus, further study of
this type of exercise may facilitate the prescription of time-
efficient exercise applicable to a broad age range of patients.
Moreover, continuous exercise therapies are usually drawn
from prescriptive approaches for adults that may not be suit-
able, or enjoyable, for children and, therefore, difficult to incor-
porate into their daily life.
The objectives of this study were 1) to determine the effect
of moderate-intensity, continuous exercise (MICE) and high-
intensity, intermittent exercise (HIIE) on the inflammatory
and growth factor response in children with CF, and 2) to com-
pare these responses with healthy matched-controls. We hy-
pothesized that 1) HIIE would produce a lower inflammatory
response and a greater growth factor response in children with
CF, because this exercise environment would be most condu-
cive to growth, and 2) children with CF would have a greater
inflammatory response and similar growth factor response
compared to matched-controls.
2. Methods
2.1. Participants
Twelve children with CF (2 females) and twelve healthy
matched-controls participated in this study. Children who could
not perform reproducible pulmonary function tests were excluded
from the study. Participants' characteristics are shown in Table 1.
Children with CF and controls were matched by gender and bio-
logical age, as determined by the estimated years from the age of
peak height velocity (PHV) [40]. Seven patients with CF were on
non-steroidal anti-inflammatory drugs (NSAIDs) and/or inhaled,
or nasal spray corticosteroids. One participant was diagnosed
with cirrhosis of the liver. Baseline values for immune cells, cy-
tokines, and growth factors are shown in Table 2.
2.2. Experimental design and exercise testing
The study procedures were approved by the Hamilton
Health Sciences/Faculty of Health Sciences Research Ethics
Board. Participants completed three visits. Visit 1: informed as-
sent and consent was obtained from participants and guardians,
respectively, followed by self-assessment of sexual maturity
[41], height measurements, bioelectrical impedance analysis
for body composition, a standard spirometry test, and an aero-
bic fitness test on a cycle ergometer using the McMaster All-
Out Progressive Continuous Cycling Test to determine peak
oxygen uptake (VO2peak) and peak mechanical power (PMP).
Table 1
Participants' characteristics.
CF (n=12) Matched-controls (n=12)
Chronological
age (years)
14.7±2.3 (11.3 to 17.5) 13.9±2.1 (10.5 to 17.5)
Estimated years
from age PHV
0.6±1.6 (−2.5 to 2.7) 0.7±1.5 (−2.5 to 2.7)
Height (m) 1.6±0.1 (1.42 to 1.77) 1.7±0.1 (1.45 to 1.83)
Height (z-score) −0.5±0.5 (−1.86 to 0.92)** 0.5±1.0 (−1.64 to 1.41)
Weight (kg) 49.5±11.3 (37.5 to 67.2) 55.0±9.1 (35.7 to 65.6)
Weight (z-score) −0.03±0.7 (−1.75 to 1.44)** 1.3±1.2 (−1.59 to 1.28)
FFM (kg) 39.4±10.0 (26.6 to 52.8) 44.6±9.1 (29.0 to 57.2) ‡
FM (kg) 9.5±3.1 (5.7 to 17.8) 10.7±5.4 (4.4 to 21.2) ‡
FEV1
(% predicted)
90.3±22.0 (38 to 123) 93.4±7.4 (84 to 109)
VO2peak
(mL/kg/min)
47.3±6.4 (35.9 to 55.3) * 53.1±6.7 (44.5 to 65.5)
VO2peak%
predicted
(mL/kg/min)
101.4±17.8 (73 to 141) * 114.9±11.1 (96 to 135)
PMP (W) 162±46 (93 to 240) ** 220±54 (121±284)
PMP (W/kg) 3.2±0.4 (2.5 to 3.7) ** 4.0±0.7 (2.8 to 5.2)
Values are mean±SD with range in parentheses. PHV: peak height velocity.
FFM: fat free mass. FM: fat mass. FEV1: forced expiratory volume in 1 s. VO2peak:
peak oxygen consumption. PMP: peak mechanical power. W: watts. Height and
weight z-scores were calculated using reference values of weight-for-age and
stature-for-age from the Centers for Disease Control and Prevention [52].
Reference data for FEV1 was obtained from Wang et al. [53]. Percent predicted
of VO2peak was calculated using reference data obtained from our laboratory.
Tanner stage assessment based on self-assessment of pubic hair development for
males and breast development for females [41]. Significant difference between
groups at *pb0.05, **pb0.01; ‡n=11 for matched-controls.
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individual child and always between afternoon and early eve-
ning hours. Visits 2 and 3 were scheduled a week apart and
consisted of either MICE (2×30-min bouts of cycling at an in-
tensity equivalent to 50% PMP, with 6 min rest between bouts)
or HIIE (6 series of 4×15 s bouts performed at 100% PMP,
with 1 min of rest between bouts and 6 min of rest between
each series). Gas was collected during MICE at four different
times, intermittently, throughout the session for 6 min at a
time. By design, MICE and HIIE were not matched for energy
expenditure.Table 2
Average baseline (REST) concentrations of immune cells, cytokines, and growth fa
CF (n=12)
Leukocytes 8.3±3.1 (4.5 to 14.2)*
Neutrophils 5.5±3.0 (2.8 to 11.5)*
Lymphocytes 2.0±0.6 (1.0 to 3.2)
Monocytes 0.6±0.2 (0.3 to 1.2)
IL-6 5.3±6.0 (0.8 to 20.5)*
TNF- α 1.0±1.1 (0.04 to 3.9)
TWEAK 972.8±281.8 (626.6 to 114
GH 3.1±3.5 (0.06 to 10.6)
IGF-1 206.7±57.4 (70.9 to 269.3
Values are displayed as mean±SD with range in parentheses. Immune cell counts a
factors are expressed in ng/mL. IL-6: interleukin 6. TNF-α: tumor necrosis factor a
hormone, IGF-1: insulin-like growth factor 1. Significant differences *pb0.05, **p2.3. Blood collection
At Visits 2 and 3, an indwelling catheter was placed in an
arm vein of the child after 10 min of supine rest. Blood sam-
ples were collected at rest (REST), at the mid-point of exer-
cise (EX-MID), immediately after exercise (EX-END),
following 30 min of recovery (REC-30), and following
60 min of recovery (REC-60); a portion of these samples
was processed to extract plasma. Additional blood samples
were collected at REST, EX-END, and REC-60 from which
serum was extracted.
2.4. Blood analysis
Total leukocytes, neutrophils, lymphocytes, and monocytes
were analyzed using an automated Coulter counter at the
McMaster University Medical Centre Core Laboratory. Plas-
ma samples were analyzed for IL-6, TNF-α, GH, and IGF-1,
while serum samples were analyzed for TWEAK using
commercially-available enzyme-linked immunosorbent assays
(ELISA).
2.5. Statistics
Independent t-tests (PASW version 18.0, SPSS, Inc., Chica-
go, IL) were used to compare variables including FEV1, VO2-
peak, and PMP. In addition, the power output between MICE
and HIIE was evaluated using dependent t-tests for children
with CF and controls separately. Two-way ANOVAs (Statistica
version 5.0, Statsoft, Inc., Tulsa, OK) were performed on base-
line concentrations (2 factors: group [CF, control] by exercise
type [MICE, HIIE]) to determine differences between groups,
between exercise types, or between groups and exercise types.
One-way repeated measures ANOVAs were performed on ab-
solute concentrations of all blood markers in response to each
exercise in children with CF and matched-controls, separately.
When an exercise effect was present, two-way repeated mea-
sures ANOVAs were performed on the magnitude of change
(Δ) from REST values between [1] MICE and HIIE in children
with CF, and [2] children with CF and matched-controls sepa-
rately for MICE and HIIE. In addition, comparisons between
children with CF on corticosteroid and/or NSAIDs (n=7),ctors.
Matched-controls (n=12)
5.7±1.5 (4.5 to 9.2)
* 2.8±10 (1.9 to 5.4)
2.2±0.5 (1.7 to 3.1)
0.5±0.2 (0.3 to 0.9)
1.2±0.9 (0.5 to 3.7)
1.1±0.3 (0.6 to 1.6)
0.6) 953.4±228.5 (595.9 to 1361.50)
3.0±2.9 (0.1 to 8.4)
) 210.1±65.5 (73.9 to 296.3)
re expressed in 109/L. Inflammatory cytokines are expressed in pg/mL. Growth
lpha. TWEAK: tumor necrosis related weak inducer of apoptosis. GH: growth
b0.01 between CF and controls.
111T. Nguyen et al. / Journal of Cystic Fibrosis 11 (2012) 108–118children with CF not on corticosteroid and/or NSAIDs (n=5),
and the matched-controls (n=12) were performed on the mag-
nitude of change from REST values using two-way repeated
measures ANOVAs on all blood markers. Tukey's HSD post
hoc analysis, which accounts for multiple mean comparisons,
was performed for all significant ANOVA tests to determine spe-
cific mean differences. Alpha level was set at pb0.05.
3. Results
3.1. Baseline (resting) concentrations
Our participants had similar levels of all blood markers (GH,
IGF-1, TNF-α, IL-6 and TWEAK) at the start of both experi-
mental sessions (i.e., REST). Thus, samples were pooled sepa-
rately for children with CF and controls to compare CF and
control values at REST. At REST, children with CF had higher
average concentrations of leukocytes, neutrophils, and IL-6
compared to controls (Table 2).
3.2. Exercise intensity (power output)
The power output for children with CF during MICE and
HIIE was 1.6±0.2 W/kg and 3.3±0.4 W/kg, respectively. For
matched controls, MICE was 2.0±0.4 W/kg and HIIE was
4.1±0.7 W/kg. Significant differences were seen betweenTable 3
Immune response to MICE and HIIE in children with CF and matched-controls.
REST EX-MID
MICE
Leukocytes
CF 8.36±3.04 9.03±3.18
Controls 5.47±1.40 6.98±1.99**
Neutrophils
CF 5.41±2.96 5.87±3.01
Controls 2.56±0.89 3.27±1.22
Lymphocytes
CF 2.14±0.78 2.38±0.75
Controls 2.21±0.58 2.88±0.95*
Monocytes
CF 0.60±0.19 0.61±0.21
Controls 0.46±0.15 0.57±0.16*
HIIE
Leukocytes
CF 8.28±3.74 8.79±3.61
Controls 5.90±1.76 6.56±1.67**
Neutrophils
CF 5.50±3.67 5.78±3.53
Controls 3.06±1.49 3.39±1.34
Lymphocytes
CF 1.92±0.53 2.05±0.52
Controls 2.09±0.46 2.34±0.49
Monocytes
CF 0.60±0.26 0.67±0.24
Controls 0.50±0.20 0.54±0.20
Values are displayed as mean±SD. Immune cell counts are expressed in 109/L. MI
exercise. REST: pre-exercise, EX-MID: midpoint of exercise, EX-END: end of exer
differences *pb0.05, **pb0.01, ***pb0.001 compared to REST values.MICE and HIIE in children with CF (pb0.001) and in
matched-controls (pb0.001). Oxygen consumption during
MICE was ~65% VO2peak for both groups.
3.3. Cystic fibrosis — MICE versus HIIE
Immune cell subsets. Children with CF had an increase from
REST in all immune cell subsets with MICE, while only the
total leukocyte pool and not individual subsets was increased
in response to HIIE (Table 3). In MICE, the magnitude of
change from REST was greater than HIIE in leukocytes at
REC-30 and REC-60 (Fig. 1A); in neutrophils at REC-30 and
REC-60 (Fig. 1B); and in lymphocytes at EX-END (Fig. 1C).
There were no differences in the magnitude of change from
REST in monocytes between exercises (Fig. 1D).
Cytokines. In MICE, IL-6 concentrations at EX-END, REC-
30, and REC-60 were greater than at REST, while HIIE had no
effect on IL-6 (Table 4). The magnitude of change from REST
in IL-6 was significantly greater for MICE than HIIE (main ef-
fect for exercise, pb0.05) (Fig. 2); however, there was no exer-
cise type× time interaction. Exercise had no effect on TNF-α or
TWEAK.
Growth factors. MICE and HIIE stimulated an increase in
circulating GH from REST at EX-MID, and MICE continued
to increase GH from REST at EX-END, while HIIE did not
(Fig. 3A). In MICE, the magnitude of change from REST wasEX-END REC-30 REC-60
10.26±2.68** 10.09±3.39** 10.74±3.50***
8.09±2.75*** 7.27±2.52*** 8.22±2.88***
6.48±2.62 7.06±3.01** 8.10±3.24***
3.87±1.59** 4.33±2.13*** 5.34±2.57***
2.83±0.88*** 2.19±0.69 1.99±0.65
3.22±1.34*** 2.26±0.72 2.27±0.70
0.78±0.22* 0.67±0.23 0.61±0.28
0.68±0.18*** 0.49±0.13 0.52±0.16
8.96±3.65* 8.23±3.38 8.32±3.20
6.72±1.83*** 6.01±1.85 6.33±1.74
5.93±3.55 5.40±3.34 5.41±3.07
3.33±1.54 3.17±1.33 3.33±1.30
2.07±0.53 1.99±0.50 1.98±0.49
2.41±0.57* 2.11±0.52 2.07±0.67
0.65±0.27 0.63±0.19 0.68±0.22
0.70±0.55 0.46±0.20 0.54±0.1
CE: moderate-intensity, continuous exercise. HIIE: high-intensity, intermittent
cise, REC-30: 30 min into recovery, REC-60: 60 min into recovery. Significant
Fig. 1. Change in immune cells in response to MICE and HIIE in children with CF. (A) Leukocytes, (B) Neutrophils, (C) Lymphocytes, and (D) Monocytes. Values
are displayed as mean±SD. Δ: change in concentration from REST. MICE: moderate-intensity, continuous exercise. HIIE: high-intensity, intermittent exercise. EX-
MID: midpoint of exercise, EX-END: end of exercise, REC-30: 30 min into recovery, REC-60: 60 min into recovery. Δ between MICE and HIIE is significantly
different at *pb0.01, **pb0.001 for the specific time point indicated.
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type of exercise had an effect on IGF-1.
3.4. CF versus matched-controls — MICE
Immune cell subsets. In children with CF, leukocytes at EX-
END, REC-30, and REC-60; neutrophils at REC-30 and REC-
60; lymphocytes at EX-END; and monocytes at EX-END were
greater than at REST. In the matched-controls, leukocytes at
EX-MID, EX-END, REC-30, and REC-60; neutrophils at EX-
END, REC-30, and REC-60; lymphocytes at EX-MID and
EX-END; and monocytes at EX-MID and EX-END were great-
er than at REST (Table 3). The magnitude of change from
REST for each immune cell subset (at each time point) was
not different between groups.
Cytokines. In children with CF, IL-6 at EX-END, REC-30,
and REC-60 was greater than at REST (Table 4). In the
matched-controls, IL-6 at EX-END, REC-30 and REC-60 was
greater than at REST. The magnitude of change from REST
for IL-6 was not different between groups. MICE had no effect
on TNF-α or TWEAK in either group.
Growth factors. In children with CF as inmatched-contorls, GH
at EX-MID and EX-ENDwas greater than at REST (Table 4). The
magnitude of change fromREST for GHwas not different between
groups. MICE had no effect on IGF-1 in either group.
3.5. CF versus matched-controls — HIIE
Immune cell subsets. In children with CF, leukocytes at EX-
END was greater than at REST (Table 3). In matched-controls,leukocytes at EX-MID and EX-END; and lymphocytes at EX-
END were greater than at REST. The magnitude of change
from REST for leukocytes and lymphocytes was not different
between groups. HIIE did not affect neutrophils, lymphocytes,
or monocytes in children with CF, and did not affect neutro-
phils or monocytes in the matched-controls.
Cytokines. In children with CF, none of the measured in-
flammatory cytokines were affected by HIIE (Table 4). In the
matched-control group, IL-6 at REC-60 was greater than at
REST, and TWEAK at REC-60 was lower than at REST. De-
spite the absence of an effect of HIIE on inflammatory cyto-
kines in children with CF, the magnitudes of change from
REST for IL-6 and TWEAK were not statistically different be-
tween groups (Fig. 4A and 4.B). HIIE had no effect on TNF-α
in either group.
Growth factors. In children with CF, GH at EX-MID was
greater than at REST. In the matched-controls, GH at EX-
MID and EX-END was greater than at REST (Table 4). Despite
the absent of an increase in GH at EX-END in children with
CF, the magnitude of change from REST for GH was not statis-
tically different between groups (Fig. 4C). HIIE did not have an
effect on IGF-1 in either group.
3.6. Effects of anti-inflammatory drugs
The magnitudes of change from REST for immune cells, cy-
tokines, or growth factors are presented in Tables 5 and 6 for
the three groups, and for MICE and HIIE. The use of NSAIDs
and/or corticosteroids did not affect the immune cell, cytokine,
or growth factor response to exercise.
Fig. 2. Average magnitude of change in IL-6 in response to MICE and HIIE in
children with CF. Values are displayed as mean±SD. Δ: change in concentra-
tion from REST values. MICE: moderate-intensity, continuous exercise. HIIE:
high-intensity, intermittent exercise. Δ between MICE and HIIE is significantly
different at *pb0.05.
Table 4
Inflammatory cytokine and growth factor response to MICE and HIIE in children with CF and matched-control.
REST EX-MID EX-END REC-30 REC-60
MICE
IL-6
CF 4.12±5.65 4.45±5.27 5.90±6.44* 6.76±6.83*** 6.14±6.08**
Controls 0.90±0.51 1.06±0.51 2.26±0.58*** 2.92±0.52*** 2.47±0.47***
TNF-α
CF 1.06±1.15 1.17±1.11 1.15±1.08 1.28±1.29 1.19±1.10
Controls 1.04±0.32 1.09±0.40 1.20±0.51 1.17±0.49 1.13±0.37
TWEAK
CF 939.57±318.80 – 901.93±191.24 – 844.51±209.57
Controls 916.55±261.03 – 963.65±203.03 – 900.49±215.55
GH
CF 2.30±4.54 20.43±19.73*** 15.49±13.33** 5.56±4.05 2.89±2.46
Controls 3.16±4.75 16.13±8.26*** 16.21±9.08*** 7.71±7.28 4.00±5.14
IGF-1
CF 201.96±56.42 190.72±52.17 199.15±59.61 193.93±53.37 190.12±53.79
Controls 205.08±65.99 196.53±63.57 199.72±66.06 206.09±70.07 201.55±70.57
HIIE
IL-6
CF 6.56±7.75 5.29±5.71 5.37±5.39 5.57±5.49 5.47±5.52
Controls 1.51±1.57 1.45±1.57 1.68±1.81 1.78±1.63 1.89±1.61**
TNF-α
CF 1.03±1.02 1.25±0.94 1.32±1.13 1.19±1.16 1.17±1.10
Controls 1.10±0.38 1.17±0.48 1.11±0.46 1.21±0.50 1.18±0.46
TWEAK
CF 1005.95±337.06 – 862.82±339.76 – 821.39±276.18
Controls 990.24±241.90 – 888.12±246.50 – 807.79±271.32*
GH
CF 3.99±4.50 9.61±5.64*** 7.20±3.41 3.14±2.37 1.59±1.80
Controls 2.85±3.47 11.06±9.42** 11.34±6.70** 5.72±4.02 2.16±1.23
IGF-1
CF 211.53±64.14 209.19±63.65 214.18±65.19 211.94±66.22 210.83±64.79
Controls 215.09±70.00 215.06±72.52 215.97±68.79 223.71±69.45 217.52±66.94
Values are displayed as mean±SD. Inflammatory cytokines are expressed in pg/mL. Growth factors are expressed in ng/mL. IL-6: interleukin 6. TNF-α: tumor
necrosis factor alpha. TWEAK: tumor necrosis related weak inducer of apoptosis. GH: growth hormone, IGF-1: insulin-like growth factor 1. MICE: moderate-inten-
sity, continuous exercise. HIIE: high-intensity, intermittent exercise. REST: pre-exercise, EX-MID: midpoint of exercise, EX-END: end of exercise, REC-30: 30 min
into recovery, REC-60: 60 min into recovery. Significant differences *pb0.05, **pb0.01, ***pb0.001 compared to REST values.
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The main findings from this study demonstrate that in children
with CF HIIE elicited a lower inflammatory and growth factor
response compared to MICE. In HIIE, the only effect was an
increase in the total leukocyte pool, but when examined sepa-
rately, the individual components of the leukocyte population
did not increase significantly with exercise. Conversely, MICE
elicited an inflammatory response with an increase from rest in
all immune cells, and a greater change in leukocytes and neutro-
phils when compared with HIIE, supporting our hypothesis.
These results may be due to the difference in duration between
the two types of exercise as neutrophilia during exercise is
thought to be duration-dependent rather than intensity-
dependent [31]. However, while our CF patients and matched-
controls completed 6 min of intermittent exercise with no change
in neutrophils, a study conducted by Rosa et al. [42] reported
increases in neutrophils immediately after 6 min of continuous
exercise at 70% VO2max in healthy children and in children
with exercise-induced asthma. Thus, even if total duration ofexercise is the same, continuous exercise is more likely to
increase neutrophils than intermittent exercise.
The inflammatory mediators IL-6, TNF-α, and TWEAK
have been shown to inhibit growth and promote muscle protein
Fig. 3. Growth hormone (GH) response to MICE and HIIE in children with CF. (A) Absolute concentration in GH response, (B) Change in GH from REST. Values
are displayed as mean±SD. Δ: change in concentration from REST values. MICE: moderate-intensity, continuous exercise. HIIE: high-intensity, intermittent exer-
cise. REST: pre-exercise, EX-MID: midpoint of exercise, EX-END: end of exercise, REC-30: 30 min into recovery, REC-60: 60 min into recovery. Concentration is
significantly different at **pb0.01, ***pb0.001 from REST.Δ between MICE and HIIE are significantly different at †pb0.01, ‡pb0.001 for the specific time point
indicated.
Fig. 4. Change in IL-6 (A), TWEAK (B), and GH (C) in response to HIIE in
children with CF and matched-controls. Values are displayed as mean±SD.
Δ: change in concentration from REST values. EX-MID: midpoint of exercise,
EX-END: end of exercise, REC-30: 30 min into recovery, REC-60: 60 min into
recovery. The magnitudes of change from REST were similar in all markers
during HIIE.
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altered by exercise in children with CF was IL-6 in response
to MICE. The absence of an IL-6 response to HIIE may
prove to be beneficial to CF patients suffering from systemic in-
flammation, including our participants as they already had
higher resting levels of IL-6 compared to matched-controls.
However, exercise-induced production of muscle-derived IL-6
is thought to be anti-inflammatory [43]. Thus, the paradoxical
roles of IL-6 make it difficult to fully understand its effect
under exercise conditions, especially in a clinical population
such as CF. More research is needed to determine whether
exercise-induced increases in IL-6 play a more pro-
inflammatory or anti-inflammatory role in the CF population.
Regardless, HIIE did not exacerbate existing levels of circulat-
ing cytokines in patients.
The growth factors GH and IGF-1 of patients with CF are of
interest because circulating levels of IGF-1, for example, tend
to be lower than in healthy individuals [44] and GH treatment
increases lean muscle mass and reduces muscle catabolism in
children with CF [16]. To our knowledge, this is the first
study that has compared the GH response to moderate-
intensity, continuous exercise and high-intensity, intermittent
exercise in children with CF. Contrary to our hypothesis, the
change in GH from REST was greater for MICE. The highest
GH level we measured was at EX-MID for both exercises;
and although the magnitude of GH secretion at this time point
was greater for MICE, further calculations found that the
amount secreted per min of exercise was greater for HIIE. An
increase of ~1.9 ng/ml/min of exercise was observed for HIIE
and ~0.6 ng/ml/min for MICE, which would indicate that the
intermittent and more intense exercise was more efficient at in-
ducing GH release. These results are supported by findings in
the adult literature that suggest that when aerobic and anaerobic
exercises are matched for duration and work accomplished, an-
aerobic exercise results in greater levels of GH secretion [45].
To our knowledge, no exercise studies have observed an in-
crease in IGF-1 in children. This is consistent with findings
from the current study as no exercise effects were seen with
IGF-1. In adults, IGF-1 can increase 10 min into a bout of exer-
cise followed by a decrease back to baseline during exercise;
IGF-1 mobilization during exercise has been suggested to be
Table 5
Effect of corticosteriods and/or non-steriodial anti-inflammatory drugs on the magnitude of change from REST in immune cells in response to MICE and HIIE.
EX-MID EX-END REC-30 REC-60 p value for main effect for group p value for group by time interaction
MICE
Δ Leukocytes
CF on drugs 0.96±1.23 2.19±1.53 1.52±1.15 2.23±1.49 0.51 0.71
CF not on drugs 0.26±1.26 1.50±1.38 2.02±2.31 2.60±2.44
Controls 1.52±0.91 2.62±1.77 1.80±1.58 2.75±1.90
Δ Neutrophils
CF on drugs 0.52±0.80 0.82±0.96 1.21±1.11 2.45±1.40 0.79 0.91
CF not on drugs 0.37±0.53 1.43±0.75 2.26±2.17 3.04±2.39
Controls 0.72±0.43 1.31±0.90 1.78±1.50 2.79±1.96
Δ Lymphocytes
CF on drugs 0.39±0.21 0.97±0.55 0.15±0.23 −0.11±0.18 0.30 0.64
CF not on drugs 0.03±0.23 0.30±0.50 −0.09±0.51 −0.19±0.57
Controls 0.67±0.54 1.01±0.91 0.05±0.38 0.07±0.61
Δ Monocytes
CF on drugs 0.02±0.08 0.23±0.13 0.07±0.18 −0.05±0.27 0.62 0.49
CF not on drugs 0.00±0.11 0.10±0.06 0.08±0.13 0.10±0.16
Controls 0.11±0.11 0.23±0.15 0.03±0.11 0.07±0.10
HIIE
Δ Leukocytes
CF on drugs 0.41±0.87 0.54±0.94 −0.33±0.71 −0.23±1.14 0.39 0.66
CF not on drugs 0.66±1.01 0.88±1.15 0.34±1.06 0.45±0.76
Controls 0.66±0.54 0.82±0.73 0.11±0.40 0.43±0.53
Δ Neutrophils
CF on drugs 0.04±0.47 0.21±0.70 −0.48±0.52 −0.45±0.97 0.06 0.29
CF not on drugs 0.62±0.76 0.74±0.85 0.43±0.77 0.42±0.54
Controls 0.33±0.39 0.27±0.62 0.11±0.44 0.28±0.58
Δ Lymphocytes
CF on drugs 0.24±0.27 0.24±0.20 0.13±0.21 0.14±0.24 0.42 0.36
CF not on drugs −0.01±0.25 0.05±0.18 −0.02±0.23 −0.04±0.27
Controls 0.25±0.22 0.32±0.31 0.02±0.30 −0.02±0.56
Δ Monocytes
CF on drugs 0.12±0.14 0.05±0.18 0.04±0.14 0.10±0.15 0.82 0.56
CF not on drugs 0.01±0.08 0.03±0.12 0.01±0.08 0.05±0.09
Controls 0.04±0.08 0.20±0.55 −0.04±0.07 0.04±0.08
Values are displayed as mean±SD. Immune cell counts are expressed in 109/L. MICE: moderate-intensity, continuous exercise. HIIE: high-intensity, intermittent
exercise. EX-MID: midpoint of exercise, EX-END: end of exercise, REC-30: 30 min into recovery, REC-60: 60 min into recovery. Δ: change in concentration
from resting values. Children with CF on corticosteroid and/or NSAIDs: n=7, children with CF not on corticosteroid and/or NSAIDs: n=5, matched-controls: n=12.
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current study was 22 min after the start of intermittent exercise
(considering exercise+ rest time). It may have been more appro-
priate to have samples taken earlier into the exercise session in
order to see changes in IGF-1. IGF-1 may be a more adequate
indicator of growth promotion than GH since IGF-1 directly in-
fluences growth by initiating cellular changes [13]. Future stud-
ies will need to account for the possibly transient increase in
IGF-1 and schedule blood samples around this increase in order
to more clearly assess the IGF-1 response to exercise, as this
has not yet been established in the pediatric exercise literature.
In comparing responses between children with CF and
healthy matched-controls, our hypothesis that children with
CF would have a greater inflammatory response and similar
growth factor response compared to matched-controls, based
on a previous study [1], was not supported. Instead, exercise re-
sponses at certain time points were seen in the matched-
controls, but absent in children with CF. In addition, GH
returned to resting concentrations earlier in the CF group. The
absence of a response to exercise at certain time points mayin part be due to the NSAIDs and corticosteroid medication taken
by some childrenwith CF, as these drugs are known to alter inflam-
mation [1]. However, unlike the work of Tirakitsoontorn et al. [1],
we found no difference in the cytokine response to exercise be-
tween children with CF on NSAIDs and/or corticosteroid medi-
cation and matched-controls or patients with CF not on these
medications. Despite the absence of some exercise responses in
children with CF that were seen in controls, the magnitude of
change from REST in all blood markers was similar between
groups.
To our knowledge, this is the first study to report the effects of
exercise on circulating TWEAK concentrations. Resting levels of
TWEAK have been measured in humans with and without chron-
ic inflammation [47]. Levels are elevated in adults with rheuma-
toid arthritis [47] compared to controls, suggesting that TWEAK
may be involved in the pathology of these diseases. In fact,
TWEAK is involved in skeletal muscle degradation [29]. Results
from the current study indicate that high-intensity intermittent ex-
ercise can reduce circulating TWEAK levels. Furthermore, the de-
crease in TWEAK with HIIE was observed in our matched-
Table 6
Effect of corticosteriods and/or non-steroidal anti-inflammatory drugs on the change in inflammatory cytokine and growth factors from baseline for MICE and HIIE.
EX-MID EX-END REC-30 REC-60 p value for main
effect for group
p value for group
by time interaction
MICE
Δ GH
CF on drugs 17.31±16.00 11.34±7.36 3.64±4.45 1.18±3.22 0.94 0.73
CF not on drugs 19.28±28.17 15.76±20.48 2.72±7.01 −0.24±8.05
Controls 12.96±9.48 13.05±11.13 4.54±9.63 0.83±7.61
Δ IGF-1
CF on drugs −13.48±17.08 −6.36±21.92 −7.86±26.88 −16.97±14.62 0.75 0.07
CF not on drugs −8.09±23.29 2.17±28.73 −8.25±8.19 −4.65±21.74
Controls −8.56±13.74 −5.36±13.58 1.01±16.31 −3.53±12.27
Δ IL-6
CF on drugs 0.19±0.88 1.90±1.86 2.92±2.17 2.52±3.09 0.45 0.82
CF not on drugs 0.54±0.48 1.61±1.08 2.26±1.28 1.31 ±0.76
Controls 0.16±0.17 1.36±0.47 2.02±0.70 1.56±0.66
Δ TNF-α
CF on drugs 0.12±0.27 0.13±0.23 0.17±0.33 0.18±0.28 0.61 0.15
CF not on drugs 0.09±0.15 0.03±0.26 0.28±0.20 0.06±0.26
Controls 0.05±0.21 0.17±0.27 0.14±0.27 0.10±0.15
Δ TWEAK
CF on drugs – −85.72±221.65 – −81.56±216.00 0.42 0.40
CF not on drugs – 29.66±278.68 – −113.96±301.44
Controls – 47.10±161.21 – −16.06±190.19
HIIE
Δ GH
CF on drugs 5.78±6.61 3.96±5.46 −0.39±4.55 −1.74±4.52 0.36 0.78
CF not on drugs 5.41±6.60 2.18±4.06 −1.49±3.85 3.32±4.81
Controls 8.21±10.07 8.49±8.65 2.87±6.32 −0.69±4.09
Δ IGF-1
CF on drugs 3.79±18.48 4.80±19.05 14.04±31.39 0.70±23.24 0.52 0.22
CF not on drugs −10.93±25.38 −0.36±8.52 −18.70±37.06 −2.66±17.72
Controls −0.04±24.61 0.88±30.90 8.62±25.68 2.42±21.10
Δ IL-6
CF on drugs −1.96±4.57 −1.19±3.18 −1.68±3.52 −2.09±3.78 0.06 0.98
CF not on drugs −0.30±0.52 −0.19±0.61 −0.02±0.65 0.30±1.32
Controls −0.06±0.20 0.18±0.35 0.28±0.44 0.39±0.44
Δ TNF-α
CF on drugs 0.29±0.25 0.39±0.69 0.13±0.27 0.20±0.25 0.19 0.40
CF not on drugs 0.14±0.20 0.16±0.33 0.21±0.27 0.07±0.26
Controls 0.07±0.20 0.01±0.23 0.11±0.17 0.08±0.28
Δ TWEAK
CF on drugs – −104.63±337.47 – −73.17±246.13 0.43 0.37
CF not on drugs – −197.03±303.14 – 340.51±144.80
Controls – −102.12±214.37 – −182.45±275.39
Values are displayed as mean±SD. Inflammatory cytokines are expressed in pg/mL. Growth factors are expressed in ng/mL. GH: growth hormone, IGF-1: insulin-like
growth factor 1, IL-6: interleukin 6. TNF-α: tumor necrosis factor alpha, TWEAK: tumor necrosis related weak inducer of apoptosis. MICE: moderate-intensity, con-
tinuous exercise. HIIE: high-intensity, intermittent exercise. EX-MID: midpoint of exercise, EX-END: end of exercise, REC-30: 30 min into recovery, REC-60:
60 min into recovery.Δ: change in concentration from resting values. Children with CF on corticosteroid and/or NSAIDs: n=7, children with CF not on corticosteroid
and/or NSAIDs: n=5, matched-controls: n=12.
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crease in TWEAK is a normal response to exercise.
Findings from this study contrast with those of the only
other known study on the inflammatory and growth factor re-
sponse to exercise in children with CF, insofar as we did not
observe an exaggerated inflammatory response in children
with CF compared to matched-controls, or an exaggerated re-
sponse in children with CF taking NAISD/corticosteroids.
The differences between studies may be due to several reasons.
First, our children with CF had better FEV1 values compared to
the participants of Tirakitsoontorn et al. [1]. While that studyreported no significant correlation between the IL-6 response
to exercise and FEV1 in children with CF, our results suggest
otherwise (r=−0.646, pb0.05). Second, Tirakitsoontorn et
al. [1] did not report FEV1 values for their controls, thus, it
is unknown whether pulmonary function in the CF patients
and controls were different. Third, our matched-controls and
children with CF were matched by biological maturity, while
Tirakitsoontorn et al. [1] did not report if, or how, their groups
were matched. Controlling for biological age is important because
the inflammatory response to exercise is influenced by maturity
status [48].
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On average, our patients were similar in pulmonary function
to matched-controls and had normal percent predicted values of
aerobic fitness. Thus, the clinical application of the results from
this study may only be appropriate for children with CF with a
good current health status. Another limitation of our study is
that we did not measure GH more frequently to capture its pul-
satility. It is possible that the effects of exercise on GH could be
observed well-after 1 h of recovery, although such measure-
ments were beyond the focus of this study.
Although this study provides novel information on the in-
flammatory and growth factor response to exercise in children
with CF, results are limited to acute bouts of exercise. Further
steps should be taken to determine the inflammatory and
growth factor response to different forms of exercise training.
Exercise can lower inflammation at rest in adults with a chronic
inflammatory disease [49], a finding that would prove to be es-
pecially beneficial if true in pediatric patients with chronic in-
flammatory diseases such as CF. There have been no studies
on the effects of exercise training on inflammatory and growth
factors in children with an inflammatory disease [50]; thus, ex-
ploration of this area will provide insight into optimal types of
exercise programs that can reduce inflammation while promot-
ing growth. It may also be possible to determine whether
exercise-induced changes in inflammation actually have a ben-
efit to tissue adaptation. In addition, since many training studies
with CF patients have focused on slowing the decline, main-
taining or improving FEV1 and VO2peak [8–10,51], efforts
should be made to investigate which type of exercise is best
at maintaining or improving FEV1 and VO2peak while reducing
inflammation and improving growth.6. Conclusion
In assessing the inflammatory and growth factor responses
to continuous versus intermittent exercise, it was found that in-
termittent exercise did not elicit an inflammatory response, but
is capable of elevating circulating GH above resting levels.
These findings demonstrate that exercise designed to mimic
the natural physical activity pattern of children does not result
in major immune or inflammatory perturbation but does induce
an increased GH, which has previously been associated with
muscle growth and retention in children with CF. Although
larger increases in GH were observed with continuous exercise,
the increases in immune cell counts and IL-6 were also greater.
Therefore, exercise prescriptions aimed at avoiding or minimiz-
ing inflammation while promoting growth should further inves-
tigate incorporating short bouts of intermittent, high-intensity
exercise.Acknowledgments
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